LINC01900

Across TCGA pan-cancer cohorts, LINC01900 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01900’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01900 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01900 is over-expressed in tumor, although a few such as CHOL and THCA show the opposite, repressed pattern.

HNSC, CHOL, and THCA are the cancer types where LINC01900 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01900 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.045	.006	7	view →
CHOL	Male	All	−0.296	.002	4	view →
THCA	All	II,III,IV	−0.040	.008	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC01900–HNSC

Open the HNSC breakdown →